Bristol-Myers Squibb
BMY
BMY
1,448 hedge funds and large institutions have $77.5B invested in Bristol-Myers Squibb in 2015 Q1 according to their latest regulatory filings, with 108 funds opening new positions, 467 increasing their positions, 630 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
2% more call options, than puts
Call options by funds: $624M | Put options by funds: $614M
0.13% less ownership
Funds ownership: 72.38% → 72.24% (-0.13%)
26% less repeat investments, than reductions
Existing positions increased: 467 | Existing positions reduced: 630
Holders
1,448
Holding in Top 10
77
Calls
$624M
Puts
$614M
Top Buyers
| 1 | +$262M | |
| 2 | +$213M | |
| 3 | +$209M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$147M |
| 5 |
AIM
abrdn Investment Management
Edinburgh,
United Kingdom
|
+$136M |
Top Sellers
| 1 | -$406M | |
| 2 | -$358M | |
| 3 | -$282M | |
| 4 |
Morgan Stanley
New York
|
-$229M |
| 5 |
State Street
Boston,
Massachusetts
|
-$112M |